Restoration, Not Bypass: Otoferlin Gene Therapy and a New Era in Hearing Loss Treatment

Audiologists should be aware that FDA-approved otoferlin gene therapy (Otarmeni) is now a biological treatment option for patients with confirmed biallelic OTOF-associated SNHL; refer eligible patients to specialized otolaryngology or gene therapy centers for evaluation.